More Evidence that GLP-1s May Reduce Risk of Vision-Robbing Eye Diseases

(MedPage Today) — Patients taking GLP-1 receptor agonists (GLP-1RA) had a lower likelihood of developing age-related macular degeneration (AMD) compared to patients using other glucose-lowering or lipid-lowering medications, a large retrospective…